Herpes Zoster Treatment
For herpes zoster (shingles), initiate oral antiviral therapy with valacyclovir 1 g three times daily or famciclovir 500 mg three times daily for 7 days, starting within 72 hours of rash onset, combined with aggressive pain management using gabapentin or pregabalin for neuropathic pain. 1, 2
Antiviral Therapy
First-Line Treatment
The evidence strongly favors valacyclovir or famciclovir over acyclovir for herpes zoster treatment. Meta-analysis demonstrates that both valacyclovir and famciclovir provide superior pain reduction compared to acyclovir, with a 36-46% reduction in pain risk at 21-30 days and a number needed to treat of only 3 patients 2. These agents offer better pharmacokinetics and more convenient dosing schedules.
Recommended regimens:
- Valacyclovir 1 g orally three times daily for 7 days (preferred)
- Famciclovir 500 mg orally three times daily for 7 days (preferred)
- Acyclovir 800 mg orally five times daily for 7-10 days (acceptable but less convenient)
Critical Timing
Start treatment within 72 hours of rash onset to maximize benefit in reducing disease severity, duration of eruption, and acute pain intensity 1, 3, 4. Treatment initiated beyond 72 hours may still benefit patients with new lesion formation, severe pain, or immunocompromise.
Special Populations
Immunocompromised patients (HIV, transplant recipients, cancer patients):
- Require higher doses: acyclovir 800 mg orally five times daily or famciclovir 500 mg three times daily
- Continue therapy until complete lesion crusting
- For severe disease: IV acyclovir 10 mg/kg every 8 hours 1, 5
- Monitor for acyclovir resistance if lesions persist despite treatment
Severe disease requiring hospitalization (disseminated infection, CNS involvement, pneumonitis):
- IV acyclovir 10 mg/kg every 8 hours for 7-10 days 1
Pain Management
Acute Pain (During Active Infection)
Multimodal approach based on pain severity:
Mild to moderate pain:
- NSAIDs or acetaminophen as first-line
- Add tramadol if inadequate response
Moderate to severe pain:
- Gabapentin: Start 300 mg daily, titrate to 900-3600 mg/day in divided doses
- Pregabalin: Start 75 mg twice daily, titrate to 150-300 mg twice daily
- Short-term opioids (oxycodone, morphine) for breakthrough pain during acute phase 1, 4
Adjunctive measures:
- Topical lidocaine for localized pain relief
- Good wound care to prevent secondary bacterial infection
Postherpetic Neuralgia (PHN) Prevention and Treatment
PHN develops in 10-20% of herpes zoster cases, increasing to 50% in patients over 85 years 6. Early antiviral treatment with valacyclovir or famciclovir is the only proven pharmacologic intervention to reduce PHN risk 3.
If PHN develops (pain persisting >3 months after rash resolution):
First-line agents:
- Gabapentin 900-3600 mg/day in divided doses
- Pregabalin 150-600 mg/day in divided doses
- Tricyclic antidepressants (amitriptyline 25-150 mg at bedtime, nortriptyline 25-100 mg at bedtime)
Second-line agents:
- Topical lidocaine 5% patches (up to 3 patches for 12 hours daily)
- Capsaicin 8% patch (single application by healthcare provider)
- Long-acting opioids if other treatments fail 4
Common Pitfalls to Avoid
Do not use topical acyclovir - it is substantially less effective than oral therapy and should be avoided 7, 8
Do not delay treatment waiting for laboratory confirmation - diagnosis is clinical based on characteristic unilateral dermatomal vesicular rash
Do not underdose immunocompromised patients - they require higher antiviral doses and longer treatment duration
Do not use high-dose valacyclovir (>3 g/day) in immunocompromised patients - associated with hemolytic uremic syndrome/thrombotic thrombocytopenic purpura 7
Do not assume acyclovir resistance without confirmation - if lesions persist on treatment, consult infectious disease; foscarnet 40 mg/kg IV every 8 hours is the alternative 7
Ophthalmic and Disseminated Herpes Zoster
Herpes zoster ophthalmicus (involvement of V1 dermatome):
- Requires immediate ophthalmology consultation
- Same antiviral regimens but do not delay treatment
- Higher risk of vision-threatening complications 1
Ramsay Hunt syndrome (facial nerve involvement):
- Same antiviral therapy plus corticosteroids (prednisone 60 mg daily for 5-7 days with taper)
Prevention
Vaccination is the most effective prevention strategy: